Efficacy and safety of 3-month dosing regimen of degarelix in Japanese subjects with prostate cancer: A phase III study-Reference-Cited by-同舟云学术

Efficacy and safety of 3-month dosing regimen of degarelix in Japanese subjects with prostate cancer: A phase III study

Published:2018-05-23 Issue:6 Volume:109 Page:1920-1929
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Ozono Seiichiro¹,Tsukamoto Taiji²,Naito Seiji³,Horie Shigeo⁴,Ohashi Yasuo⁵,Uemura Hiroji⁶,Yokomizo Yumiko⁷,Fukasawa Satoshi⁸,Kusuoka Hidehito⁹^ORCID,Akazawa Rio⁹,Saito Masako⁹,Akaza Hideyuki¹⁰

Affiliation:

1. Hamamatsu University School of Medicine; Shizuoka Japan

2. Sapporo Medical University; Hokkaido Japan

3. Harasanshin Hospital; Fukuoka Japan

4. Department of Urology; Juntendo University Graduate School of Medicine; Tokyo Japan

5. Chuo University; Tokyo Japan

6. Yokohama City University Medical Center; Kanagawa Japan

7. Yokohama City University; Kanagawa Japan

8. Chiba Cancer Center; Chiba Japan

9. Astellas Pharma Inc.; Tokyo Japan

10. Strategic Investigation on Comprehensive Cancer Network; The University of Tokyo; Tokyo Japan

Funder

Astellas Pharm Inc

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cas.13600/fullpdf

Reference22 articles.

1. GLOBOCAN 2012 v1.0 Estimated cancer incidence, mortality, and prevalence worldwide http://globocan

2. NCCN Clinical Practice Guidelines in Oncology Prostate cancer. version 2.2017 https://www.nccn.org/professionals/physician_gls/f_guidelines.asp

3. Nadir testosterone within first year of androgen-deprivation therapy (ADT) predicts for time to castration-resistant progression: a secondary analysis of the PR-7 trial of intermittent versus continuous ADT;Klotz;J Clin Oncol,2015

4. The European Association of Urology Prostate cancer guidelines http://uroweb.org/guideline/prostate-cancer

5. Flare associated with LHRH-agonist therapy;Thompson;Rev Urol,2001

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long acting injectables for the treatment of prostate cancer;Journal of Drug Delivery Science and Technology;2024-10

2. Exploring the top 30 drugs associated with drug-induced constipation based on the FDA adverse event reporting system;Frontiers in Pharmacology;2024-09-02

3. Cardiovascular Effects of GnRH Antagonists Compared With Agonists in Prostate Cancer;JACC: CardioOncology;2023-10

4. Patients’ preference and time to finish injection for GnRH agonist and GnRH antagonist in Japanese prostate cancer patients;2023-08-25

5. Comparison of Quality of Life and Injection Site Reactions After Switching from Degarelix 80 mg to 480 mg in Advanced Prostate Cancer: A Prospective Trial;Anticancer Research;2023-03-27